Concepedia

Author

Junko Ban

Takeda (Japan)

Also Known As

Junko Ban

7

Publications

144

Citations

6

H-Index

12

Concepts

All Affiliations

Takeda (Japan)
JB

About

Junko Ban is an author at Takeda (Japan) specializing in medicine, drug discovery, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

55

2

Natural Sciences

1

1

13

3

Biochemistry

1

1

13

4

Biomedical Engineering

1

1

11

5

Endocrinology

1

1

31

Junko Ban

×

6

Publications

138

Citations

6

H-Index

YearCitations

Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil), a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825

Yukihiro Ikeda, Junko Ban, Tomoyasu Ishikawa,

Chemical and Pharmaceutical Bulletin

2008

40

Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide

Hisanori Matsui, Tsuneo Masaki, Y. Akinaga,

European Journal of Pharmacology

2014

31

Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-<scp>d</scp>-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH<sub>2</sub>(TAK-448), with Highly Potent Testosterone-Suppressive Activity and Excellent Water Solubility

Naoki Nishizawa, Yoshihiro Takatsu, Satoshi Kumano,

Journal of Medicinal Chemistry

2016

29

Physicochemically and Pharmacokinetically Stable Nonapeptide KISS1 Receptor Agonists with Highly Potent Testosterone-Suppressive Activity

Taiji Asami, Naoki Nishizawa, Hisanori Matsui,

Journal of Medicinal Chemistry

2014

14

Discovery of Novel and Potent Orally Active Calcium-Sensing Receptor Antagonists that Stimulate Pulselike Parathyroid Hormone Secretion: Synthesis and Structure−Activity Relationships of Tetrahydropyrazolopyrimidine Derivatives

Masato Yoshida, Akira Mori, Etsuo Kotani,

Journal of Medicinal Chemistry

2011

13

Novel and potent calcium-sensing receptor antagonists: Discovery of (5R)-N-[1-ethyl-1-(4-ethylphenyl)propyl]-2,7,7-trimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide monotosylate (TAK-075) as an orally active bone anabolic agent

Masato Yoshida, Akira Mori, Shinji Morimoto,

Bioorganic & Medicinal Chemistry

2011

11

Page 1